Relay Therapeutics, Inc.
RLAY
$3.19
-$0.075-2.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.73% | 4.45% | -13.30% | 2.52% | -27.02% |
| Total Depreciation and Amortization | -2.41% | -0.07% | -1.94% | 1.45% | 0.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.48% | 58.68% | -43.91% | 60.31% | -23.81% |
| Change in Net Operating Assets | 118.94% | -159.57% | 60.99% | 138.73% | 28.44% |
| Cash from Operations | 22.93% | -14.05% | -30.82% | 43.58% | -18.29% |
| Capital Expenditure | 100.00% | -1,963.64% | 99.38% | -1,408.47% | 80.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.03% | -376.41% | 270.08% | -79.41% | -16.90% |
| Cash from Investing | 122.98% | -376.97% | 332.53% | -82.35% | -16.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.63% | 14,095.14% | -96.85% | 123.20% | 131.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.63% | 14,095.14% | -96.85% | 123.20% | 131.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -259.09% | 194.15% | -305.27% | 220.26% | -239.92% |